ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors
Background: ACAP1 plays a key role in endocytic recycling, which is essential for the normal function of lymphocytes. However, the expression and function of ACAP1 in lymphocytes have rarely been studied. Methods: Large-scale genomic data, including multiple bulk RNA-sequencing datasets, single-cell...
Main Authors: | Qiyi Yi, Youguang Pu, Fengmei Chao, Po Bian, Lei Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/23/5951 |
Similar Items
-
Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma
by: Ning Wang, et al.
Published: (2022-01-01) -
The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma
by: Mahshid Panahi, et al.
Published: (2023-01-01) -
The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Signaling
by: Vrouyr Bilemjian, et al.
Published: (2022-06-01) -
Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
by: Biaoru Li
Published: (2022-10-01) -
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer
by: Stephanie Dorta-Estremera, et al.
Published: (2019-09-01)